GitLab (GTLB) 10-Q3 Sep 242025 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares shares in Millions	6 Months Ended
Cover - shares shares in Millions	Jul. 31, 2024	Aug. 19, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2024
Document Transition Report	false
Entity File Number	001-40895
Entity Registrant Name	GITLAB INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1861035
Title of 12(b) Security	Class A common stock, par value $0.0000025per share
Trading Symbol	GTLB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Address, Address Line One	251 Little Falls Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19808
Entity Central Index Key	0001653482
Current Fiscal Year End Date	--01-31
Current Fiscal Year Focus	2025
Current Fiscal Period Focus	Q2
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		136.5
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		24

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Jul. 31, 2024		Jan. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents	[1]	$ 438,616		$ 287,996
Short-term investments	[1]	644,488		748,289
Accounts receivable, net of allowance for doubtful accounts of $679 and $673 as of July 31, 2024 and January 31, 2024, respectively	[1]	165,001		166,731
Deferred contract acquisition costs, current	[1]	33,841		32,300
Prepaid expenses and other current assets	[1]	32,410		45,601
Total current assets	[1]	1,314,356		1,280,917
Property and equipment, net	[1]	2,899		2,954
Operating lease right-of-use assets		482	[1]	405
Goodwill	[1]	16,017		8,145
Intangible assets, net	[1]	21,867		1,733
Deferred contract acquisition costs, non-current	[1]	15,753		19,317
Other non-current assets	[1]	4,888		4,390
TOTAL ASSETS	[1]	1,376,262		1,317,861
CURRENT LIABILITIES:
Accounts payable	[1]	3,219		1,738
Accrued expenses and other current liabilities	[1]	272,164		286,178
Accrued compensation and benefits	[1]	29,117		35,809
Deferred revenue, current	[1]	362,348		338,348
Total current liabilities	[1]	666,848		662,073
Deferred revenue, non-current	[1]	14,732		23,794
Other non-current liabilities	[1]	6,678		14,060
TOTAL LIABILITIES	[1]	688,258		699,927
Commitments and contingencies (Note 14)	[1]
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of July 31, 2024 and January 31, 2024; no shares issued and outstanding as of July 31, 2024 and January 31, 2024	[1]	0		0
Additional paid-in capital	[1]	1,833,786		1,718,661
Accumulated deficit	[1]	(1,191,517)		(1,149,822)
Accumulated other comprehensive income	[1]	570		2,335
Total GitLab stockholders’ equity	[1]	642,839		571,174
Noncontrolling interests	[1]	45,165		46,760
TOTAL STOCKHOLDERS’ EQUITY	[1]	688,004		617,934
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	[1]	1,376,262		1,317,861
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	0		0
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	$ 0		$ 0

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands		Jul. 31, 2024	Jan. 31, 2024
Allowance for doubtful accounts		$ 679	$ 673
STOCKHOLDERS’ EQUITY:
Preferred stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Preferred stock, shares authorized (in shares)		50,000,000	50,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Assets of consolidated variable interest entity	[1]	$ 1,376,262	$ 1,317,861
Liabilities of consolidated variable interest entity	[1]	688,258	699,927
Variable Interest Entity, Primary Beneficiary
STOCKHOLDERS’ EQUITY:
Assets of consolidated variable interest entity		44,980	47,625
Liabilities of consolidated variable interest entity		$ 6,464	$ 6,080
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		1,500,000,000	1,500,000,000
Common stock, shares issued (in shares)		136,462,000	114,670,000
Common stock, shares outstanding (in shares)		136,462,000	114,670,000
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		250,000,000	250,000,000
Common stock, shares issued (in shares)		23,963,000	42,887,000
Common stock, shares outstanding (in shares)		23,963,000	42,887,000

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenue	$ 182,584	$ 139,581	$ 351,771	$ 266,459
Cost of revenue	21,370	14,696	40,146	28,635
Gross profit	161,214	124,885	311,625	237,824
Operating expenses:
Sales and marketing	97,778	92,116	190,202	178,653
Research and development	61,273	49,007	115,413	99,394
General and administrative	43,168	37,819	100,655	72,067
Total operating expenses	202,219	178,942	406,270	350,114
Loss from operations	(41,005)	(54,057)	(94,645)	(112,290)
Interest income	12,827	9,112	24,857	16,427
Other income (expense), net	1,032	(1,330)	465	(1,077)
Loss before income taxes and loss from equity method investment	(27,146)	(46,275)	(69,323)	(96,940)
Loss from equity method investment, net of tax	0	(917)	0	(1,665)
Provision for (benefit from) income taxes	(39,420)	4,016	(26,710)	5,502
Net income (loss)	12,274	(51,208)	(42,613)	(104,107)
Net loss attributable to noncontrolling interest	(675)	(1,128)	(918)	(1,558)
Net income (loss) attributable to GitLab	$ 12,949	$ (50,080)	$ (41,695)	$ (102,549)
Net income (loss) per share attributable to GitLab Class A and Class B common stockholders:
Basic (in USD per share)	$ 0.08	$ (0.33)	$ (0.26)	$ (0.67)
Diluted (in USD per share)	$ 0.08	$ (0.33)	$ (0.26)	$ (0.67)
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders:
Basic (in shares)	159,677	153,644	158,973	152,683
Diluted (in shares)	166,346	153,644	158,973	152,683
Subscription—self-managed and SaaS
Revenue	$ 163,181	$ 122,096	$ 314,360	$ 233,287
Cost of revenue	16,630	10,871	30,469	21,762
License—self-managed and other
Revenue	19,403	17,485	37,411	33,172
Cost of revenue	$ 4,740	$ 3,825	$ 9,677	$ 6,873

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 12,274	$ (51,208)	$ (42,613)	$ (104,107)
Foreign currency translation adjustments	(5,178)	(365)	(2,546)	(1,222)
Net change in unrealized gains (losses) on available-for-sale securities	1,620	(194)	(101)	1,303
Comprehensive income (loss) including noncontrolling interest	8,716	(51,767)	(45,260)	(104,026)
Net loss attributable to noncontrolling interest	(675)	(1,128)	(918)	(1,558)
Foreign currency translation adjustments attributable to noncontrolling interest	(768)	(1,338)	(882)	(2,406)
Comprehensive loss attributable to noncontrolling interest	(1,443)	(2,466)	(1,800)	(3,964)
Comprehensive income (loss) attributable to GitLab	$ 10,159	$ (49,301)	$ (43,460)	$ (100,062)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 824,725				$ 0	$ 0	$ 1,497,373	$ (725,648)	$ (705)	$ 53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					7,358,000	(7,358,000)
Issuance of common stock related to vested exercised stock options (in shares)						2,060,000
Issuance of common stock related to vested exercised stock options	17,933						17,933
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested (in shares)					1,038,000
Charitable donation of common stock (in shares)			133,389	134,000
Charitable donation of common stock	5,350		$ 5,300				5,350
Vesting of early exercised stock options	809						809
Stock-based compensation expense	78,698						81,359			(2,661)
Change in noncontrolling interest ownership							(503)			503
Other comprehensive income (loss)	81								2,487	(2,406)
Net income (loss)	(104,107)							(102,549)		(1,558)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240				$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601				$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2023					96,240,000	56,453,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					6,213,000	(6,213,000)
Issuance of common stock related to vested exercised stock options (in shares)						940,000
Issuance of common stock related to vested exercised stock options	10,320						10,320
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(2,000)
Issuance of common stock related to RSUs vested (in shares)					679,000
Charitable donation of common stock (in shares)			52,647	53,000
Charitable donation of common stock	2,675		$ 2,700				2,675
Vesting of early exercised stock options	292						292
Stock-based compensation expense	46,368						46,555			(187)
Change in noncontrolling interest ownership							(124)			124
Other comprehensive income (loss)	(559)								779	(1,338)
Net income (loss)	(51,208)							(50,080)		(1,128)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240				$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	831,240				0	0	1,610,072	(828,197)	1,782	47,583
Stockholders' Equity, beginning balance	$ 617,934	[1]			$ 0	$ 0	1,718,661	(1,149,822)	2,335	46,760
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024					114,670,000	42,887,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					19,855,000	(19,855,000)
Issuance of common stock related to vested exercised stock options (in shares)	931,000					931,000
Issuance of common stock related to vested exercised stock options	$ 10,074						10,074
Issuance of common stock under employee stock purchase plan (in shares)					252,000
Issuance of common stock under employee stock purchase plan	7,932						7,932
Issuance of common stock related to RSUs vested (in shares)					1,565,000
Charitable donation of common stock (in shares)			120,241		120,000
Charitable donation of common stock	5,914		$ 5,900				5,914
Vesting of early exercised stock options	189						189
Stock-based compensation expense	91,221						91,425			(204)
Change in noncontrolling interest ownership							(409)			409
Other comprehensive income (loss)	(2,647)								(1,765)	(882)
Net income (loss)	(42,613)							(41,695)		(918)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024					136,462,000	23,963,000
Stockholders' Equity, ending balance at Jul. 31, 2024	688,004	[1]			$ 0	$ 0	1,833,786	(1,191,517)	570	45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	614,358				$ 0	$ 0	1,768,947	(1,204,466)	3,360	46,517
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2024					132,670,000	26,212,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					2,619,000	(2,619,000)
Issuance of common stock related to vested exercised stock options (in shares)						370,000
Issuance of common stock related to vested exercised stock options	4,981						4,981
Issuance of common stock under employee stock purchase plan (in shares)					252,000
Issuance of common stock under employee stock purchase plan	7,932						7,932
Issuance of common stock related to RSUs vested (in shares)					854,000
Charitable donation of common stock (in shares)			67,015	67,000
Charitable donation of common stock	2,957		$ 2,900				2,957
Vesting of early exercised stock options	91						91
Stock-based compensation expense	48,969						48,877			92
Change in noncontrolling interest ownership							1			(1)
Other comprehensive income (loss)	(3,558)								(2,790)	(768)
Net income (loss)	12,274							12,949		(675)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024					136,462,000	23,963,000
Stockholders' Equity, ending balance at Jul. 31, 2024	688,004	[1]			$ 0	$ 0	1,833,786	(1,191,517)	570	45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 688,004	[1]			$ 0	$ 0	$ 1,833,786	$ (1,191,517)	$ 570	$ 45,165

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (42,613)	$ (104,107)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense	91,221	78,698
Change in fair value of acquisition related contingent consideration	3,750	0
Charitable donation of common stock	5,914	5,350
Amortization of intangible assets	3,420	1,125
Depreciation expense	1,681	2,206
Amortization of deferred contract acquisition costs	22,946	20,619
Loss from equity method investment	0	2,108
Net amortization of premiums or discounts on short-term investments	(9,141)	(8,494)
Unrealized foreign exchange loss (gain), net	(258)	825
Other non-cash expense (income), net	301	(103)
Changes in assets and liabilities:
Accounts receivable	1,225	25,281
Prepaid expenses and other current assets	13,271	(4,248)
Deferred contract acquisition costs	(20,955)	(18,137)
Other non-current assets	(497)	(721)
Accounts payable	1,350	(1,023)
Accrued expenses and other current liabilities	(21,633)	1,183
Accrued compensation and benefits	(6,902)	2,611
Deferred revenue	14,838	11,175
Other non-current liabilities	(8,083)	1,800
Net cash provided by operating activities	49,835	16,148
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(263,258)	(334,996)
Proceeds from maturities of short-term investments	376,099	272,984
Purchases of property and equipment	(1,551)	(533)
Payments for business combination, net of cash acquired	(20,210)	0
Payments for asset acquisition	(7,314)	0
Escrow payment related to business combination, after acquisition date	0	(2,500)
Other investing activities	457	0
Net cash provided by (used in) investing activities	84,223	(65,045)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	10,073	17,777
Issuance of common stock under employee stock purchase plan	7,932	7,751
Net cash provided by financing activities	18,005	25,528
Impact of foreign exchange on cash and cash equivalents	(1,443)	(1,308)
Net increase (decrease) in cash and cash equivalents	150,620	(24,677)
Cash and cash equivalents at beginning of period	287,996	297,902
Cash and cash equivalents at end of period	438,616	273,225
Supplemental disclosure of cash flow information:
Cash paid for income taxes	1,803	4,187
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	189	809
Unpaid property and equipment in accrued expenses	87	0
Unpaid direct transaction costs related to the asset acquisition in accrued expenses	$ 346	$ 0

Organization and Description of

Organization and Description of Business	6 Months Ended
Organization and Description of Business	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. The Company operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ending January 31, 2025 and the fiscal year ended January 31, 2024, respectively. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation. Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2024 . Recently Issued Accounting Pronouncements Aside from the new accounting pronouncements already discussed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024, there were no additional pronouncements issued or effective during the period that would materially affect our condensed consolidated financial statements.

Revenues

Revenues	6 Months Ended
Revenues	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Subscription—self-managed and SaaS $ 163,181 89 % $ 122,096 87 % $ 314,360 89 % $ 233,287 87 % Subscription—self-managed 111,546 61 86,659 62 215,219 61 166,246 62 SaaS 51,635 28 35,437 25 99,141 28 67,041 25 License—self-managed and other $ 19,403 11 % $ 17,485 13 % $ 37,411 11 % $ 33,172 13 % License—self-managed 15,802 9 14,624 11 30,639 9 27,979 11 Professional services and other 3,601 2 2,861 2 6,772 2 5,193 2 Total revenue $ 182,584 100 % $ 139,581 100 % $ 351,771 100 % $ 266,459 100 % Total Revenue by Geographic Location The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 United States $ 149,357 $ 114,054 $ 286,883 $ 217,016 Europe 28,889 22,245 56,541 43,202 Asia Pacific 4,338 3,282 8,347 6,241 Total revenue $ 182,584 $ 139,581 $ 351,771 $ 266,459 During the three and six months ended July 31, 2024 , the United States accounted for 82% of total revenue for each period presented. During the three and six months ended July 31, 2023, the United States accounted for 82% and 81% of total revenue, respectively. No other individual country exceeded 10% of total revenue for any of the periods presented. The Company operates its business as a single operating segment. Deferred Revenue During the three and six months ended July 31, 2024, $133.9 million and $218.5 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the periods presented. During the three and six months ended July 31, 2023, $101.6 million and $157.5 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue bala nce at the beginning of the periods presented. Remaining Performance Obligations As of July 31, 2024 and January 31, 2024, the aggregate amount of the transaction price allocated to bill ed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $747.9 million and $673.8 million, respectively. As of July 31, 2024, the Company expects to recognize approximately 64% of the transaction price as product or services revenue over the next 12 months and 87% over the next 24 months. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary. The Company uses various distribution channels. As of July 31, 2024 , one partner represented 15% of the accounts receivable balance; while as of January 31, 2024 , two channel partners represented 12% and 13% of the accounts receivable balance, respectively. There were no individual customers whose balance represented more than 10% of accounts receivable as of July 31, 2024 and January 31, 2024. There were no individual customers whose revenue represented more than 10% of total revenue during the three and six months ended July 31, 2024 and 2023.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	6 Months Ended
Cash Equivalents and Short-Term Investments	Jul. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	4. Cash Equivalents and Short-Term Investments The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands): As of July 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 350,712 $ — $ — $ 350,712 Level 2: Cash equivalents (1) U.S. Treasury securities 8,946 — — 8,946 Commercial paper 2,984 — (1) 2,983 Total cash equivalents 362,642 — (1) 362,641 Short-term investments Commercial paper 19,208 — (7) 19,201 Corporate debt securities 196,403 193 (249) 196,347 U.S. Agency securities 51,420 14 (53) 51,381 U.S. Treasury securities 377,412 359 (212) 377,559 Total short-term investments 644,443 566 (521) 644,488 Level 2 total 656,373 566 (522) 656,417 Total cash equivalents and short-term investments $ 1,007,085 $ 566 $ (522) $ 1,007,129 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of July 31, 2024, in addition to cash of $76.0 million. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 187,175 $ — $ — $ 187,175 Level 2: Cash equivalents (1) U.S. Treasury securities 15,909 — (2) 15,907 Commercial paper 3,962 — (1) 3,961 Total cash equivalents 207,046 — (3) 207,043 Short-term investments Commercial paper 23,229 14 (1) 23,242 Corporate debt securities 231,219 740 (250) 231,709 U.S. Agency securities 56,324 29 (136) 56,217 U.S. Treasury securities 437,369 141 (389) 437,121 Total short-term investments 748,141 924 (776) 748,289 Level 2 total 768,012 924 (779) 768,157 Total cash equivalents and short-term investments $ 955,187 $ 924 $ (779) $ 955,332 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instruments such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company uses the specific-identification method to determine any realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the three and six months ended July 31, 2024 and 2023 , the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments. During the three and six months ended July 31, 2024 , the Company recorded $12.8 million and $24.9 million of interest income on cash and cash equivalents and short-term investments, respectively, which includes $4.2 million and $9.1 million of net amortization of premiums or discounts on short-term investments during the three and six months ended July 31, 2024, respectively. During the three and six months ended July 31, 2023 , the Company record ed $9.1 million and $16.4 million of interest income on cash equivalents and short-term investments, respectively, which includes $4.9 million and $8.5 million of net amortization of premiums or discounts on short-term investments during the three and six months ended July 31, 2023, respectively. The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses July 31, 2024 U.S. Agency securities $ 32,661 $ (38) $ 13,729 $ (15) $ 46,390 $ (53) Commercial paper 19,074 (8) — — 19,074 (8) Corporate debt securities 75,764 (102) 43,796 (147) 119,560 (249) U.S. Treasury securities 199,799 (170) 25,135 (42) 224,934 (212) Total cash equivalents and short-term investments $ 327,298 $ (318) $ 82,660 $ (204) $ 409,958 $ (522) Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2024 U.S. Agency securities $ 35,979 $ (53) $ 11,386 $ (83) $ 47,365 $ (136) Commercial paper 15,462 (2) — — 15,462 (2) Corporate debt securities 85,998 (192) 15,485 (58) 101,483 (250) U.S. Treasury securities 139,567 (192) 41,193 (199) 180,760 (391) Total cash equivalents and short-term investments $ 277,006 $ (439) $ 68,064 $ (340) $ 345,070 $ (779) The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2024 January 31, 2024 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 546,547 $ 546,368 $ 619,286 $ 618,765 Due between 1 year to 2 years 97,896 98,120 128,855 129,524 Total $ 644,443 $ 644,488 $ 748,141 $ 748,289 All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations. Liabilities are measured at fair value on a recurring basis. The Company has contingent cash consideration from a business combination which is determined based upon the satisfaction of certain defined operational milestones and remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liability is included in Level 3 of the fair value measurement hierarchy. The Company reassessed the fair value of outstanding operational milestones d uring the three and six months ended July 31, 2024 and 2023. As of July 31, 2024, the contingent consideration was revalued to $7.4 million, resulting in a change in fair value of $3.8 million which is included in general and administrative expenses in the condensed consolidated statement of operations for the three months ended July 31, 2024 . There were no changes to the fair value during the three and six months ended July 31, 2023. The Company had $7.4 million and $3.6 million of Level 3 contingent consideration as of July 31, 2024 and January 31, 2024, respectively. Interest accretion expense on contingent cash consideration was immaterial and $0.1 million for the three and six months ended July 31, 2024, respectively, and immaterial and $0.1 million for the three and six months ended July 31, 2023, respectively.

Supplemental Financial Statemen

Supplemental Financial Statement Information	6 Months Ended
Supplemental Financial Statement Information	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Statement Information	5. Supplemental Financial Statement Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2024 January 31, 2024 Income tax liability related to BAPA (1) $ 231,379 $ 258,675 Accrued expenses 15,496 11,499 Acquisition related liabilities (2) 8,455 3,608 Income taxes payable 8,309 2,212 Customer refunds payable 3,398 3,019 Indirect taxes payable 2,579 3,928 ESPP employee contributions 2,224 2,827 Operating lease liabilities, current 324 410 Total accrued expenses and other current liabilities $ 272,164 $ 286,178 (1) Refer to “Note 12. Income Taxes” for a discussion on the unrecognized tax benefits related to the BAPA. (2) $1.0 million relates to Oxeye acquisition founder holdback (see Note 6. Acquisitions) and $7.4 million relates to Opstrace acquisition (see Note 4. Cash Equivalents and Short-Term Investments ). Other Inc ome (Expense), Net Other income (expense), net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Foreign exchange gains (losses), net $ 867 $ (1,268) $ 230 $ (994) Other income (expense), net 165 (62) 235 (83) Total other income (expense), net $ 1,032 $ (1,330) $ 465 $ (1,077)

Acquisitions

Acquisitions	6 Months Ended
Acquisitions	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	6. Acquisitions Rezilion On May 23, 2024 (the “Asset Acquisition Date”), the Company completed its acquisition of certain assets, primarily software intellectual property, of Rezilion Inc. and its subsidiary, Rezilion Ltd. (collectively, “Rezilion”) for approximately $7.3 million in cash. The Rezilion transaction was accounted for as an asset acquisition because substantially all of the fair value of gross assets acquired were concentrated in the developed intellectual property. Acquisition-related direct transaction costs were capitalized as a component of the cost of the assets acquired. On the Asset Acquisition Date, the fair value of the developed technology was $7.7 million including $0.4 million of acquisition-related direct costs. The developed technology acquired has an estimated useful life of three years. Oxeye On March 20, 2024 (the “Acquisition Date”), the Company completed the acquisition of Oxeye Security Limited (“Oxeye”), a cloud-native application security and risk management solution company based in Israel. The Company believes this acquisition will allow the Company to strengthen its product offerings. The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands): Closing cash consideration $ 16,737 Cash held in escrow 3,593 Total consideration $ 20,330 Total consideration includes $3.6 million deposited in an escrow account as partial security for post-closing indemnification claims made within 15 months of the Acquisition Date. As the Company is not the legal owner of the escrow account, it is not recorded on the condensed consolidated balance sheet as of July 31, 2024. As part of the acquisition, there was also a holdback in the amount of $3.2 million (the “holdback”). The holdback will be paid to the two co-founders (the “founder holdback”) in three equal tranches of 33.3%. The first such payment will be paid if certain milestones are achieved on or before the first anniversary of the closing date, provided such founder is employed by the Company upon completion of the milestones. The second and third tranches will be paid provided such founder is employed by the Company on the second and third anniversaries of the closing dates, respectively. As the founder holdback arrangement represents compensation for post-combination services, the Company has excluded the entire $3.2 million from the purchase price to be allocated, and will recognize the amount as expense over the period of services rendered after factoring in the likelihood of achieving the milestones in the first year. As of July 31, 2024, the Company determined that the milestones attached to the first payment tranche would be achieved in the third quarter of fiscal year 2025 and has recorded $0.9 million and $1.0 million in general and administrative expenses in its condensed consolidated statement of operations for the three and six months ended July 31, 2024, respectively. Acquisition related transaction costs were immaterial and $1.2 million for the three and six months ended July 31, 2024, respectively, and were recorded by the Company in general and administrative expenses in its condensed consolidated statement of operations. The Company recorded the assets acquired and liabilities assumed at their estimated fair values, with the difference between the fair value of the net assets acquired and the purchase consideration reflected in goodwill. The total purchase price of $20.3 million was allocated using information available to the Company at the time of acquisition. The Company may continue to adjust the preliminary purchase price allocation after obtaining more information regarding asset valuations, liabilities assumed, tax-related items and revisions of preliminary estimates. During the three and six months ended July 31, 2024 , there were no measurement period adjustments identified and recorded. The following table reflects the fair values of assets acquired and liabilities assumed (in thousands): Cash and cash equivalents $ 120 Developed technology 16,276 Goodwill 8,055 Prepaid expenses and other current assets 121 Accrued expenses and payroll (3,582) Deferred tax liability (660) Net assets acquired $ 20,330 As of March 20, 2024, developed technology of the acquired business had an estimated useful life of three years. The fair value of the developed technology intangible asset was estimated using the replacement cost method, which utilizes assumptions for the cost to replace it, such as time and resources required, as well as a theoretical profit margin and opportunity costs. The goodwill is primarily attributed to the synergies expected to be realized following the acquisition. The goodwill is not deductible for Israeli income tax purposes. Results of operations of the business acquired have been included in the Company’s condensed consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to the Company’s condensed consolidated results of operations; and accordingly, pro forma financial statements have not been presented.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	6 Months Ended
Goodwill and Intangible Assets, Net	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	7. Goodwill and Intangible Assets, Net Goodwill The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 8,145 Acquisition of Oxeye 8,055 Foreign currency translation adjustments (183) Balance as of July 31, 2024 $ 16,017 There was no goodwill impairment for any periods presented. Intangible Assets Intangible assets, net consisted of the following (in thousands): July 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination (1) $ 22,082 $ (7,395) $ 14,687 2.4 Developed technology from asset acquisitions 8,574 (1,394) 7,180 2.8 Total $ 30,656 $ (8,789) $ 21,867 January 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (4,467) $ 1,733 0.8 Developed technology from asset acquisitions (1) 914 (914) — 0.0 Total $ 7,114 $ (5,381) $ 1,733 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. Amortization expense was $2.3 million and $3.4 million for the three and six months ended July 31, 2024, respectively, and $0.5 million and $1.1 million for the three and six months ended July 31, 2023 , respectively. As of July 31, 2024, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2025 $ 4,625 2026 7,848 2027 7,848 2028 1,546 Total future amortization $ 21,867

Team Member Benefit Plans

Team Member Benefit Plans	6 Months Ended
Team Member Benefit Plans	Jul. 31, 2024
Retirement Benefits [Abstract]
Team Member Benefit Plans	8. Team Member Benefit Plans The Company contributes to defined c ontribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $1.2 million and $3.0 million for the three and six months ended July 31, 2024, respectively, and $1.0 million and $2.7 million for the three and six months ended July 31, 2023, respectively.

Equity

Equity	6 Months Ended
Equity	Jul. 31, 2024
Equity [Abstract]
Equity	9. Equity Common Stock The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2024 January 31, 2024 Class A and Class B common stock Options issued and outstanding 7,481 8,503 Shares available for issuance under Equity Incentive Plans 29,797 24,868 RSUs and PSUs issued and outstanding 12,405 10,930 Shares reserved for issuance to charitable organizations 1,284 1,404 ESPP 6,722 5,398 Total 57,689 51,103 Equity Incentive Plans In September 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor of the Company’s 2015 Equity Incentive Plan (together the “Plans”). The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2024 January 31, 2024 Available at beginning of period 24,868 21,483 Awards authorized 7,878 7,557 RSUs and PSUs granted (4,238) (6,258) RSUs and PSUs canceled and forfeited 1,198 1,292 Options canceled and forfeited 91 777 Options repurchased — 17 Available at end of period 29,797 24,868 In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the 2021 Plan. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2024 8,503 $ 13.03 5.85 $ 499.2 Options granted — — — Options exercised (931) 10.82 — Options canceled (11) 13.75 — Options forfeited (80) 18.30 — Balances at July 31, 2024 7,481 $ 13.18 5.39 $ 284.7 Options vested at July 31, 2024 6,252 $ 12.18 5.13 $ 244.2 Options vested and expected to vest at July 31, 2024 7,481 $ 13.18 5.39 $ 284.7 During the three and six months ended July 31, 2024, the Company recorded $3.4 million and $6.9 million stock-based compensation expense related to options, respectively. During the three and six months ended July 31, 2023, the Company recorded $4.7 million and $9.5 million stock-based compensation expense related to options, respectively. As of July 31, 2024, approximately $12.9 million of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 1.2 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s RSU activity: Number of Shares (in thousands) (1) Weighted- Balances at January 31, 2024 7,701 $ 47.20 Granted 4,238 53.15 Vested (1,565) 48.70 Canceled/forfeited (1,198) 48.44 Balances at July 31, 2024 9,176 $ 49.48 (1) The table above does not include 3 million RSUs granted to the Company’s founder and the Chief Executive Officer (“CEO”) described below. These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two three and six months ended July 31, 2023, the Company recorded $29.9 million and $53.2 million stock-based compensation expense related to RSUs, respectively. As of July 31, 2024, approximately $450.6 million of total unrecognized compensation cost was related to RSUs granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 2.9 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance c ondition is set to be achieved in fiscal year 2025 and the service condition in calendar year 2025. The Company recorded $0.3 million and $0.9 million of stock-based compensation expense related to PSUs during the three and six months ended July 31, 2024 , respectively. The Company recorded a $0.1 million gain and $0.3 million of stock-based compensation expense related to PSUs during the three and six months ended July 31, 2023, respectively. As of July 31, 2024, unrecognized stock-based compensation expense related to these PSUs was $1.7 million to be recognized over a period of 1.4 years. CEO Performance Award In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. During the three and six months ended July 31, 2024, the Company recorded $0.3 million and $0.7 million of stock-based compensation expense related to the CEO RSU, respectively. During the three and six months ended July 31, 2023, the Company recorded $0.4 million and $0.8 million of stock-based compensation expense related to the CEO RSU, respectively. As measured from the grant date, the derived service period of the respective tranches ranges from 3 to 7 years. As of July 31, 2024, unrecognized stock-based compensation expense related to these RSUs was $3.6 million which will be recognized over 4.3 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members. During the quarter ended July 31, 2024, the Company’s stock price on the purchase date, May 31, 2024, was lower than the Company’s stock price on the previously applicable offering date. As a result, the offering in effect was reset with the lower stock price becoming the new offering price and rolled over to a new 24-month offering period. The reset was treated as a modification resulting in incremental expense totaling $1.0 million, which is being recognized over the remaining requisite service period as of the date of reset. The following table summarizes assumptions used in estimating the fair value of the ESPP for the new offering period in effect using the Black-Scholes option-pricing model: Three Months Ended July 31, 2024 2023 Risk-free interest rate 4.70% - 5.25% 4.22% - 5.30% Volatility 50.94% - 60.50% 40.95% - 51.00% Expected term (in years) 0.50 - 2.00 0.50 - 2.00 Dividend yield —% —% The Company rec orded $3.5 million and $6.1 million of stock-based compensation expense related to the ESPP during the three and six months ended July 31, 2024, respectively. The Company rec orded $6.7 million and $11.2 million of stock-based compensation expense related to the ESPP during the three and six months ended July 31, 2023, respectively . As of July 31, 2024, approximately $11.4 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.8 years. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Cost of revenue $ 2,076 $ 1,698 $ 3,931 $ 3,112 Sales and marketing 19,881 21,295 37,278 35,059 Research and development 16,114 12,477 28,450 24,179 General and administrative 10,898 10,898 21,562 16,348 Total stock-based compensation expense (1) $ 48,969 $ 46,368 $ 91,221 $ 78,698 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was zero for both the three and six months ended July 31, 2024 , and $3.6 million and $6.4 million for the three and six months ended July 31, 2023, respectively . Charitable Donation of Common Stock In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2024 and 2023, the Company’s board of directors approved the donation of $11.8 million and $10.7 million aggregate principal amount of shares of Class A common stock to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation, respectively. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur in four equal quarterly distributions. During the three and six months ended July 31, 2024, the Company donated 67,015 shares and 120,241 shares of Class A common stock at fair value to the Foundation, respectively. During the three and six months ended July 31, 2023, the Company donated 52,647 shares and 133,389 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $2.9 million and $5.9 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three and six months ended July 31, 2024, respectively. The donation expense of $2.7 million and $5.3 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three and six months ended July 31, 2023, respectively.

Restructuring and Other Related

Restructuring and Other Related Charges	6 Months Ended
Restructuring and Other Related Charges	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	10. Restructuring and Other Related Charges In fiscal year 2025, the Company restructured certain departments to better align functions and recognized total restructuring charges of approxima tely $0.8 million and $1.8 million during the three and six months ended July 31, 2024, respectively. In fiscal year 2024, the Company reduced its total global headcount by approximately 7% . As a result, the Company recognized total restructuring charges of approximately $0.2 million and $7.8 million during the six months ended July 31, 2023, respectively. The Company recognized severance and other termination benefit costs as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 (1) Cost of revenue $ — $ 46 $ — $ 463 Research and development 393 (12) 393 2,047 Sales and marketing 266 118 996 3,677 General and administrative 112 20 388 1,638 Total $ 771 $ 172 $ 1,777 $ 7,825 (1) Excludes stock-based compensation of $1.3 million for the six months ended July 31, 2023 . The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2024 $ 188 Charges 1,777 Cash payments (1,799) Balance as of July 31, 2024 (1) $ 166 (1) Balance is included in accrued compensation and benefits on the condensed consolidated balance sheet as of July 31, 2024.

Joint Venture and Equity Method

Joint Venture and Equity Method Investment	6 Months Ended
Joint Venture and Equity Method Investment	Jul. 31, 2024
Noncontrolling Interest [Abstract]
Joint Venture and Equity Method Investment	11. Joint Venture and Equity Method Investment Joint Venture In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation. As of July 31, 2024, the Company retains control over JiHu with its equity stake at approxima tely 54%. Since fiscal year 2023, JiHu has maintained an employee stock option plan (“JiHu 2022 ESOP”) for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan (“JiHu 2024 ESOP”) for its employees in order to grant additional shares. The fair value of restricted stock awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method; as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP (“JiHu ESOPs”). As a result of forfeitures triggered by the departure of key executives from JiHu, during the three and six months ended July 31, 2024, t he Company reversed stock-based compensation previously recorded which resulted in a $0.1 million stock-based compensation net expense and a $0.2 million net gain, respectively. As a result of forfeitures triggered by the departure of certain executives during the three and six months ended July 31, 2023, the Company reversed stock-based compensation previously recorded for such executives. The Company recorded a $0.2 million stock-based compensation net expense and a $2.7 million net gain for the three and six months ended July 31, 2023, respectively . As of July 31, 2024, approximately $9.4 million of total unrecognized compensation cost was related to the JiHu ESOPs that is expected to be recognized over 4.1 years. Operating Leases JiHu entered into two new operating leases during the six months ended July 31, 2024 and has various non-cancelable long-term operating leases maturing by May 25, 2027 with total lease payments of $0.5 million and a total present value of lease liabilities of $0.5 million. In addition, JiHu has various short-term leases. Lease expense associated with short-term leases was immaterial during the three and six months ended July 31, 2024. The Company recognized $0.1 million and $0.3 million of operating lease expense during the three and six months ended July 31, 2024 , respectively. The Company recognized $0.1 million and $0.3 million of operating lease expense during the three and six months ended July 31, 2023, respectively . The table below presents supplemental information related to operating leases for the six months ended July 31, 2024 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 1.75 Weighted-average discount rate 3.5 % Right-of-use assets obtained in exchange for new operating lease liabilities $ 372 Cash paid for amounts included in the measurement of lease liabilities $ 294 Selected Financial Information Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Revenue $ 1,775 $ 1,609 $ 3,421 $ 3,073 Cost of revenue 535 560 1,019 1,051 Gross profit 1,240 1,049 2,402 2,022 Operating expenses: Sales and marketing 1,410 1,960 3,046 4,044 Research and development 578 727 366 2,683 General and administrative 907 1,407 1,745 (37) Total operating expenses 2,895 4,094 5,157 6,690 Loss from operations (1,655) (3,045) (2,755) (4,668) Interest income 230 240 457 555 Other income (expense), net (42) 293 305 562 Net loss before income taxes (1,467) (2,512) (1,993) (3,551) Net loss $ (1,467) $ (2,512) $ (1,993) $ (3,551) Net loss attributable to noncontrolling interest $ (675) $ (1,128) $ (918) $ (1,558) July 31, 2024 January 31, 2024 Cash and cash equivalents $ 40,756 $ 43,896 Property and equipment, net 277 489 Operating lease right-of-use assets 482 405 Other assets 3,465 2,835 Total assets $ 44,980 $ 47,625 Total liabilities $ 6,464 $ 6,080 Equity Method Investment In April 2021, the Company reorganized Meltano Inc. (“Meltano”), now operating as Arch Data, Inc. (“Arch”), which started as an internal project within the Company in July 2018, into a separate legal entity. The Company recorded an impairment charge of $8.9 million in other income (expense), net in the condensed consolidated statement of operations during the year ended January 31, 2024 which reduced the equity method investment value to zero a s of January 31, 2024 . During the three and six months ended July 31, 2024, the Company recorded a loss from equity method investment of zero. During the three and six months ended July 31, 2023 , the Company recognized a loss from equity method investment of $0.9 million and $1.7 million, net of tax on the condensed consolidated statements of operations, respectively.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes For the three and six months ended July 31, 2024 , the Company recorded an income tax benefit of $39.4 million and $26.7 million on pretax loss of $27.1 million and $69.3 million , respectively . The income tax benefit for the three and six months ended July 31, 2024 was primarily related to a decrease in tax expense for unrecognized tax benefits and the Company's foreign and domestic operations. For the three and six months ended July 31, 2023 , the Company recorded income tax expense of $4.0 million and $5.5 million on pretax loss of $46.3 million and $96.9 million , respectively. The income tax expense for the three and six months ended July 31, 2023 was primarily related to an increase in tax expense for unrecognized tax benefits and the Company's foreign and domestic operations. The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax provision for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter. Under the provisions of ASC 740, Income Taxes , the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. As in prior years, the Company maintained that it was not more likely than not that the Company could recognize deferred tax assets in certain jurisdictions. The evidence evaluated by the Company included operating results during the most recent three-year period and future projections. More weight was given to historical results than to expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets. As of July 31, 2024, unrecognized tax benefits were $349.9 million, of which $160.1 million would affect the effective tax rate if recognized. The Company has classified approximately $159.5 million of unrecognized tax benefit as current tax liability due to anticipated timing of the settlement of the bilateral advance pricing agreement (“BAPA”) with the U.S. Internal Revenue Service (“IRS”) and Dutch Tax Authority (“DTA”) and their associated payments, which are expected to be made within the next 12 months. The Company is unable to reasonably estimate the timing of remaining long-term payments or the amount by which the liability will increase or decrease. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in provision for income taxes. Accrued interest and penalties were $55.4 million as of July 31, 2024 and $52.1 million as of January 31, 2024, respectively. The Company has been in BAPA negotiations between the IRS and the DTA relating to the Company’s transfer pricing arrangements between the United States and the Netherlands. In the year ended January 31, 2024, the Company for the first time discussed with the IRS and DTA a framework to finalize its transfer pricing arrangements for the proposed BAPA period consisting of tax years ending December 31, 2018 through January 31, 2026. The proposed agreements between the Company, the IRS and the DTA are not yet final; in anticipation of the agreements, $254.9 million of net tax liability was recorded in the year ended January 31, 2024, and a net reduction of $38.1 million of tax liability was recorded for the six months ended July 31, 2024 . An increase of $8.6 million was recorded in the net liability in the three months ended April 30, 2024, and a decrease of $46.7 million was recorded in the net liability in the three months ended July 31, 2024 . These amounts represent the unrecognized tax benefit relating to the BAPA. The unrecognized tax benefit represents the Company’s best estimate of the tax liability associated with the proposed agreements and their related effects. As of July 31, 2024, the Company’s U.S. federal 2018 through 2024 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company is currently under examination in the Netherlands for the tax years ended December 31, 2015 and 2016. The Company expects negotiations to continue through the end of fiscal year 2025. The Company believes that it has adequately reserved for the outcome of this audit. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.

Net Income (Loss) per Share

Net Income (Loss) per Share	6 Months Ended
Net Income (Loss) per Share	Jul. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) per Share	13. Net Income (Loss) per Share The following table sets forth basic and diluted income (loss) per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Numerator: Net income (loss) attributable to GitLab $ 12,949 $ (50,080) $ (41,695) $ (102,549) Denominator: Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic 159,677 153,644 158,973 152,683 Dilutive impact of Stock Options 5,452 — — — Dilutive impact of RSUs 1,166 — — — Dilutive impact of ESPP 51 — — — Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted 166,346 153,644 158,973 152,683 Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic $ 0.08 $ (0.33) $ (0.26) $ (0.67) Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted $ 0.08 $ (0.33) $ (0.26) $ (0.67) Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of July 31, 2024 July 31, 2023 Shares subject to outstanding common stock options — 9,933 Unvested restricted stock in connection with business combination 2 3 Unvested early exercised stock options — 63 Unvested RSUs and PSUs 6,917 11,465 Shares subject to the ESPP 222 71 Total 7,141 21,535

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Contractual Obligations and Commitments The Company’s purchase oblig ations of $135.1 million as of July 31, 2024 , represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements. Loss Contingencies In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use o f contractors in certain foreign countries. As of July 31, 2024 and January 31, 2024, the estimated liability relating to these matters was $2.1 million and $2.2 million recorded in other non-current liabilities on the condensed consolidated balance sheets, respectively. Warranties and Indemnifications The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Fiscal Year	Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ending January 31, 2025 and the fiscal year ended January 31, 2024, respectively.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Summary of Significant Accounting Policies and Recently Issued Accounting Pronouncements	Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2024 . Recently Issued Accounting Pronouncements Aside from the new accounting pronouncements already discussed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024, there were no additional pronouncements issued or effective during the period that would materially affect our condensed consolidated financial statements.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
Revenues (Tables)	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Subscription—self-managed and SaaS $ 163,181 89 % $ 122,096 87 % $ 314,360 89 % $ 233,287 87 % Subscription—self-managed 111,546 61 86,659 62 215,219 61 166,246 62 SaaS 51,635 28 35,437 25 99,141 28 67,041 25 License—self-managed and other $ 19,403 11 % $ 17,485 13 % $ 37,411 11 % $ 33,172 13 % License—self-managed 15,802 9 14,624 11 30,639 9 27,979 11 Professional services and other 3,601 2 2,861 2 6,772 2 5,193 2 Total revenue $ 182,584 100 % $ 139,581 100 % $ 351,771 100 % $ 266,459 100 %
Revenue by Geographic Location	The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 United States $ 149,357 $ 114,054 $ 286,883 $ 217,016 Europe 28,889 22,245 56,541 43,202 Asia Pacific 4,338 3,282 8,347 6,241 Total revenue $ 182,584 $ 139,581 $ 351,771 $ 266,459

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	6 Months Ended
Cash Equivalents and Short-Term Investments (Tables)	Jul. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Short Term Investments	The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands): As of July 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 350,712 $ — $ — $ 350,712 Level 2: Cash equivalents (1) U.S. Treasury securities 8,946 — — 8,946 Commercial paper 2,984 — (1) 2,983 Total cash equivalents 362,642 — (1) 362,641 Short-term investments Commercial paper 19,208 — (7) 19,201 Corporate debt securities 196,403 193 (249) 196,347 U.S. Agency securities 51,420 14 (53) 51,381 U.S. Treasury securities 377,412 359 (212) 377,559 Total short-term investments 644,443 566 (521) 644,488 Level 2 total 656,373 566 (522) 656,417 Total cash equivalents and short-term investments $ 1,007,085 $ 566 $ (522) $ 1,007,129 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of July 31, 2024, in addition to cash of $76.0 million. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 187,175 $ — $ — $ 187,175 Level 2: Cash equivalents (1) U.S. Treasury securities 15,909 — (2) 15,907 Commercial paper 3,962 — (1) 3,961 Total cash equivalents 207,046 — (3) 207,043 Short-term investments Commercial paper 23,229 14 (1) 23,242 Corporate debt securities 231,219 740 (250) 231,709 U.S. Agency securities 56,324 29 (136) 56,217 U.S. Treasury securities 437,369 141 (389) 437,121 Total short-term investments 748,141 924 (776) 748,289 Level 2 total 768,012 924 (779) 768,157 Total cash equivalents and short-term investments $ 955,187 $ 924 $ (779) $ 955,332 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million.
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment	The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses July 31, 2024 U.S. Agency securities $ 32,661 $ (38) $ 13,729 $ (15) $ 46,390 $ (53) Commercial paper 19,074 (8) — — 19,074 (8) Corporate debt securities 75,764 (102) 43,796 (147) 119,560 (249) U.S. Treasury securities 199,799 (170) 25,135 (42) 224,934 (212) Total cash equivalents and short-term investments $ 327,298 $ (318) $ 82,660 $ (204) $ 409,958 $ (522) Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2024 U.S. Agency securities $ 35,979 $ (53) $ 11,386 $ (83) $ 47,365 $ (136) Commercial paper 15,462 (2) — — 15,462 (2) Corporate debt securities 85,998 (192) 15,485 (58) 101,483 (250) U.S. Treasury securities 139,567 (192) 41,193 (199) 180,760 (391) Total cash equivalents and short-term investments $ 277,006 $ (439) $ 68,064 $ (340) $ 345,070 $ (779)
Schedule of Short Term Investments by Contractual Maturity	The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2024 January 31, 2024 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 546,547 $ 546,368 $ 619,286 $ 618,765 Due between 1 year to 2 years 97,896 98,120 128,855 129,524 Total $ 644,443 $ 644,488 $ 748,141 $ 748,289

Supplemental Financial Statem_2

Supplemental Financial Statement Information (Tables)	6 Months Ended
Supplemental Financial Statement Information (Tables)	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2024 January 31, 2024 Income tax liability related to BAPA (1) $ 231,379 $ 258,675 Accrued expenses 15,496 11,499 Acquisition related liabilities (2) 8,455 3,608 Income taxes payable 8,309 2,212 Customer refunds payable 3,398 3,019 Indirect taxes payable 2,579 3,928 ESPP employee contributions 2,224 2,827 Operating lease liabilities, current 324 410 Total accrued expenses and other current liabilities $ 272,164 $ 286,178 (1) Refer to “Note 12. Income Taxes” for a discussion on the unrecognized tax benefits related to the BAPA. (2) $1.0 million relates to Oxeye acquisition founder holdback (see Note 6. Acquisitions) and $7.4 million relates to Opstrace acquisition (see Note 4. Cash Equivalents and Short-Term Investments
Schedule of Other Income, Net	Other income (expense), net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Foreign exchange gains (losses), net $ 867 $ (1,268) $ 230 $ (994) Other income (expense), net 165 (62) 235 (83) Total other income (expense), net $ 1,032 $ (1,330) $ 465 $ (1,077)

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
Acquisitions (Tables)	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Business Acquisitions, by Acquisition	The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands): Closing cash consideration $ 16,737 Cash held in escrow 3,593 Total consideration $ 20,330 The following table reflects the fair values of assets acquired and liabilities assumed (in thousands): Cash and cash equivalents $ 120 Developed technology 16,276 Goodwill 8,055 Prepaid expenses and other current assets 121 Accrued expenses and payroll (3,582) Deferred tax liability (660) Net assets acquired $ 20,330

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	6 Months Ended
Goodwill and Intangible Assets, Net (Tables)	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 8,145 Acquisition of Oxeye 8,055 Foreign currency translation adjustments (183) Balance as of July 31, 2024 $ 16,017
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): July 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination (1) $ 22,082 $ (7,395) $ 14,687 2.4 Developed technology from asset acquisitions 8,574 (1,394) 7,180 2.8 Total $ 30,656 $ (8,789) $ 21,867 January 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (4,467) $ 1,733 0.8 Developed technology from asset acquisitions (1) 914 (914) — 0.0 Total $ 7,114 $ (5,381) $ 1,733 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of July 31, 2024, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2025 $ 4,625 2026 7,848 2027 7,848 2028 1,546 Total future amortization $ 21,867

Equity (Tables)

Equity (Tables)	6 Months Ended
Equity (Tables)	Jul. 31, 2024
Equity [Abstract]
Schedule of Stock Reserved For Future Issuance	The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2024 January 31, 2024 Class A and Class B common stock Options issued and outstanding 7,481 8,503 Shares available for issuance under Equity Incentive Plans 29,797 24,868 RSUs and PSUs issued and outstanding 12,405 10,930 Shares reserved for issuance to charitable organizations 1,284 1,404 ESPP 6,722 5,398 Total 57,689 51,103
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2024 January 31, 2024 Available at beginning of period 24,868 21,483 Awards authorized 7,878 7,557 RSUs and PSUs granted (4,238) (6,258) RSUs and PSUs canceled and forfeited 1,198 1,292 Options canceled and forfeited 91 777 Options repurchased — 17 Available at end of period 29,797 24,868
Share-based Payment Arrangement, Option, Activity	The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2024 8,503 $ 13.03 5.85 $ 499.2 Options granted — — — Options exercised (931) 10.82 — Options canceled (11) 13.75 — Options forfeited (80) 18.30 — Balances at July 31, 2024 7,481 $ 13.18 5.39 $ 284.7 Options vested at July 31, 2024 6,252 $ 12.18 5.13 $ 244.2 Options vested and expected to vest at July 31, 2024 7,481 $ 13.18 5.39 $ 284.7
Schedule of Restricted Stock Units Activity	The following table summarizes the Company’s RSU activity: Number of Shares (in thousands) (1) Weighted- Balances at January 31, 2024 7,701 $ 47.20 Granted 4,238 53.15 Vested (1,565) 48.70 Canceled/forfeited (1,198) 48.44 Balances at July 31, 2024 9,176 $ 49.48 (1)
Schedule of Estimating the Fair Value of the ESPP	The following table summarizes assumptions used in estimating the fair value of the ESPP for the new offering period in effect using the Black-Scholes option-pricing model: Three Months Ended July 31, 2024 2023 Risk-free interest rate 4.70% - 5.25% 4.22% - 5.30% Volatility 50.94% - 60.50% 40.95% - 51.00% Expected term (in years) 0.50 - 2.00 0.50 - 2.00 Dividend yield —% —%
Schedule of Share Based Compensation Expense	The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Cost of revenue $ 2,076 $ 1,698 $ 3,931 $ 3,112 Sales and marketing 19,881 21,295 37,278 35,059 Research and development 16,114 12,477 28,450 24,179 General and administrative 10,898 10,898 21,562 16,348 Total stock-based compensation expense (1) $ 48,969 $ 46,368 $ 91,221 $ 78,698 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	6 Months Ended
Restructuring and Other Related Charges (Tables)	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges	The Company recognized severance and other termination benefit costs as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 (1) Cost of revenue $ — $ 46 $ — $ 463 Research and development 393 (12) 393 2,047 Sales and marketing 266 118 996 3,677 General and administrative 112 20 388 1,638 Total $ 771 $ 172 $ 1,777 $ 7,825 (1) Excludes stock-based compensation of $1.3 million for the six months ended July 31, 2023 .
Schedule of Restructuring Reserve by Type of Cost	The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2024 $ 188 Charges 1,777 Cash payments (1,799) Balance as of July 31, 2024 (1) $ 166 (1) Balance is included in accrued compensation and benefits on the condensed consolidated balance sheet as of July 31, 2024.

Joint Venture and Equity Meth_2

Joint Venture and Equity Method Investment (Tables)	6 Months Ended
Joint Venture and Equity Method Investment (Tables)	Jul. 31, 2024
Noncontrolling Interest [Abstract]
Schedule of Supplemental Information Related to Operating Leases	The table below presents supplemental information related to operating leases for the six months ended July 31, 2024 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 1.75 Weighted-average discount rate 3.5 % Right-of-use assets obtained in exchange for new operating lease liabilities $ 372 Cash paid for amounts included in the measurement of lease liabilities $ 294
Schedule of Variable Interest Entities	Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Revenue $ 1,775 $ 1,609 $ 3,421 $ 3,073 Cost of revenue 535 560 1,019 1,051 Gross profit 1,240 1,049 2,402 2,022 Operating expenses: Sales and marketing 1,410 1,960 3,046 4,044 Research and development 578 727 366 2,683 General and administrative 907 1,407 1,745 (37) Total operating expenses 2,895 4,094 5,157 6,690 Loss from operations (1,655) (3,045) (2,755) (4,668) Interest income 230 240 457 555 Other income (expense), net (42) 293 305 562 Net loss before income taxes (1,467) (2,512) (1,993) (3,551) Net loss $ (1,467) $ (2,512) $ (1,993) $ (3,551) Net loss attributable to noncontrolling interest $ (675) $ (1,128) $ (918) $ (1,558) July 31, 2024 January 31, 2024 Cash and cash equivalents $ 40,756 $ 43,896 Property and equipment, net 277 489 Operating lease right-of-use assets 482 405 Other assets 3,465 2,835 Total assets $ 44,980 $ 47,625 Total liabilities $ 6,464 $ 6,080

Net Income (Loss) per Share (Ta

Net Income (Loss) per Share (Tables)	6 Months Ended
Net Income (Loss) per Share (Tables)	Jul. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth basic and diluted income (loss) per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Numerator: Net income (loss) attributable to GitLab $ 12,949 $ (50,080) $ (41,695) $ (102,549) Denominator: Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic 159,677 153,644 158,973 152,683 Dilutive impact of Stock Options 5,452 — — — Dilutive impact of RSUs 1,166 — — — Dilutive impact of ESPP 51 — — — Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted 166,346 153,644 158,973 152,683 Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic $ 0.08 $ (0.33) $ (0.26) $ (0.67) Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted $ 0.08 $ (0.33) $ (0.26) $ (0.67)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of July 31, 2024 July 31, 2023 Shares subject to outstanding common stock options — 9,933 Unvested restricted stock in connection with business combination 2 3 Unvested early exercised stock options — 63 Unvested RSUs and PSUs 6,917 11,465 Shares subject to the ESPP 222 71 Total 7,141 21,535

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 182,584	$ 139,581	$ 351,771	$ 266,459
Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100%	100%	100%	100%
Subscription—self-managed and SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 163,181	$ 122,096	$ 314,360	$ 233,287
Subscription—self-managed and SaaS \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	89%	87%	89%	87%
Subscription—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 111,546	$ 86,659	$ 215,219	$ 166,246
Subscription—self-managed \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	61%	62%	61%	62%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 51,635	$ 35,437	$ 99,141	$ 67,041
SaaS \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	28%	25%	28%	25%
License—self-managed and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 19,403	$ 17,485	$ 37,411	$ 33,172
License—self-managed and other \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	11%	13%	11%	13%
License—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 15,802	$ 14,624	$ 30,639	$ 27,979
License—self-managed \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	9%	11%	9%	11%
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,601	$ 2,861	$ 6,772	$ 5,193
Professional services and other \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	2%	2%	2%	2%

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 182,584	$ 139,581	$ 351,771	$ 266,459
United States
Disaggregation of Revenue [Line Items]
Total revenue	149,357	114,054	286,883	217,016
Europe
Disaggregation of Revenue [Line Items]
Total revenue	28,889	22,245	56,541	43,202
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 4,338	$ 3,282	$ 8,347	$ 6,241

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
Revenues - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Disaggregation of Revenue [Line Items]
Deferred revenue recognized	$ 133.9	$ 101.6	$ 218.5	$ 157.5
Remaining performance obligation	$ 747.9		$ 747.9		$ 673.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-08-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, next twelve months (as a percent)	64%		64%
Remaining performance obligation, next twenty four months (as a percent)	87%		87%
Accounts Receivable \| Credit Concentration Risk \| Distribution Channel One
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			15%		12%
Accounts Receivable \| Credit Concentration Risk \| Distribution Channel Two
Disaggregation of Revenue [Line Items]
Concentration risk, percentage					13%
United States \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	82%	82%	82%	81%

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	[1]	$ 438,616	$ 287,996
Cash equivalents and short-term investments, amortized cost		1,007,085	955,187
Cash equivalents and short-term investments, gross unrealized gains		566	924
Cash equivalents and short-term investments, gross unrealized losses		(522)	(779)
Cash equivalents and short-term investments, fair value		1,007,129	955,332
Level 2
Debt Securities, Available-for-sale [Line Items]
Cash equivalents and short-term investments, amortized cost		656,373	768,012
Cash equivalents and short-term investments, gross unrealized gains		566	924
Cash equivalents and short-term investments, gross unrealized losses		(522)	(779)
Cash equivalents and short-term investments, fair value		656,417	768,157
Cash and Cash Equivalents \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents		362,642	207,046
Cash equivalents, gross unrealized gains		0	0
Cash equivalents, gross unrealized losses		(1)	(3)
Cash equivalents, fair value		362,641	207,043
Short-Term Investments \| Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		644,443	748,141
Short-term investments, gross unrealized gains		566	924
Short-term investments, gross unrealized losses		(521)	(776)
Short-term investments, fair value		644,488	748,289
Money market funds \| Cash and Cash Equivalents \| Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents		350,712	187,175
Cash equivalents, fair value		350,712	187,175
U.S. Treasury securities \| Cash and Cash Equivalents \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents		8,946	15,909
Cash equivalents, gross unrealized gains		0	0
Cash equivalents, gross unrealized losses		0	(2)
Cash equivalents, fair value		8,946	15,907
U.S. Treasury securities \| Short-Term Investments \| Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		377,412	437,369
Short-term investments, gross unrealized gains		359	141
Short-term investments, gross unrealized losses		(212)	(389)
Short-term investments, fair value		377,559	437,121
Commercial paper \| Cash and Cash Equivalents \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents		2,984	3,962
Cash equivalents, gross unrealized gains		0	0
Cash equivalents, gross unrealized losses		(1)	(1)
Cash equivalents, fair value		2,983	3,961
Commercial paper \| Short-Term Investments \| Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		19,208	23,229
Short-term investments, gross unrealized gains		0	14
Short-term investments, gross unrealized losses		(7)	(1)
Short-term investments, fair value		19,201	23,242
Corporate debt securities \| Short-Term Investments \| Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		196,403	231,219
Short-term investments, gross unrealized gains		193	740
Short-term investments, gross unrealized losses		(249)	(250)
Short-term investments, fair value		196,347	231,709
U.S. Agency securities \| Short-Term Investments \| Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		51,420	56,324
Short-term investments, gross unrealized gains		14	29
Short-term investments, gross unrealized losses		(53)	(136)
Short-term investments, fair value		51,381	56,217
Cash \| Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost		$ 76,000	$ 81,000

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest and investment income	$ 12,800	$ 9,100	$ 24,900	$ 16,400
Net amortization of premiums or discounts on short-term investments	4,200	(4,900)	9,141	8,494
Contingent consideration liability, current	8,455		8,455		$ 3,608
Change in fair value of acquisition related contingent consideration			3,750	0
Accretion expense	0	0	100	100
Opstrace Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, current	7,400		7,400
Change in fair value of acquisition related contingent consideration	3,800	$ 0		$ 0
Fair Value, Inputs, Level 3 \| Opstrace Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent payment	$ 7,400		$ 7,400		$ 3,600

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	$ 327,298	$ 277,006
Less than 12 months, gross unrealized losses	(318)	(439)
12 months or greater, carrying value	82,660	68,064
12 months or greater, gross unrealized losses	(204)	(340)
Fair Value	409,958	345,070
Gross Unrealized Losses	(522)	(779)
U.S. Agency securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	32,661	35,979
Less than 12 months, gross unrealized losses	(38)	(53)
12 months or greater, carrying value	13,729	11,386
12 months or greater, gross unrealized losses	(15)	(83)
Fair Value	46,390	47,365
Gross Unrealized Losses	(53)	(136)
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	19,074	15,462
Less than 12 months, gross unrealized losses	(8)	(2)
12 months or greater, carrying value	0	0
12 months or greater, gross unrealized losses	0	0
Fair Value	19,074	15,462
Gross Unrealized Losses	(8)	(2)
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	75,764	85,998
Less than 12 months, gross unrealized losses	(102)	(192)
12 months or greater, carrying value	43,796	15,485
12 months or greater, gross unrealized losses	(147)	(58)
Fair Value	119,560	101,483
Gross Unrealized Losses	(249)	(250)
U.S. Treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	199,799	139,567
Less than 12 months, gross unrealized losses	(170)	(192)
12 months or greater, carrying value	25,135	41,193
12 months or greater, gross unrealized losses	(42)	(199)
Fair Value	224,934	180,760
Gross Unrealized Losses	$ (212)	$ (391)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Amortized cost
Due within 1 year	$ 546,547	$ 619,286
Due between 1 year to 2 years	97,896	128,855
Total	644,443	748,141
Fair Value
Due within 1 year	546,368	618,765
Due between 1 year to 2 years	98,120	129,524
Total	$ 644,488	$ 748,289

Supplemental Financial Statem_3

Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Income tax liability related to BAPA		$ 231,379	$ 258,675
Accrued expenses		15,496	11,499
Acquisition related liabilities		8,455	3,608
Income taxes payable		8,309	2,212
Customer refunds payable		3,398	3,019
Indirect taxes payable		2,579	3,928
ESPP employee contributions		2,224	2,827
Operating lease liabilities, current		$ 324	$ 410
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Total accrued expenses and other current liabilities	Total accrued expenses and other current liabilities
Total accrued expenses and other current liabilities	[1]	$ 272,164	$ 286,178
Oxeye Security Limited
Business Acquisition [Line Items]
Acquisition related liabilities		1,000
Opstrace Inc.
Business Acquisition [Line Items]
Acquisition related liabilities		$ 7,400

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_4

Supplemental Financial Statement Information - Other Income, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Foreign exchange gains (losses), net	$ 867	$ (1,268)	$ 230	$ (994)
Other income (expense), net	165	(62)	235	(83)
Total other income (expense), net	$ 1,032	$ (1,330)	$ 465	$ (1,077)

Acquisitions - Schedule of Tota

Acquisitions - Schedule of Total Consideration Transferred (Details) - Oxeye Security Limited - USD ($) $ in Thousands		6 Months Ended
	Mar. 20, 2024	Jul. 31, 2024
Business Acquisition [Line Items]
Closing cash consideration	$ 16,737
Cash held in escrow	3,593
Total consideration	$ 20,330	$ 20,300

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) $ in Thousands			3 Months Ended	6 Months Ended
Acquisitions - Narrative (Details) $ in Thousands	May 23, 2024 USD ($)	Mar. 20, 2024 USD ($) tranche co-founder	Jul. 31, 2024 USD ($)	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)
Business Acquisition [Line Items]
Number of co-founders \| co-founder		2
Change in fair value of acquisition related contingent consideration				$ 3,750	$ 0
Rezilion Asset Acquisition
Business Acquisition [Line Items]
Asset acquisition, consideration transferred	$ 7,300
Finite-lived intangible assets acquired	7,700
Acquisition related costs	$ 400
Intangible assets acquired, useful life	3 years
Oxeye Security Limited
Business Acquisition [Line Items]
Acquisition related costs			$ 0	1,200
Cash held in escrow		$ 3,593
Post-closing indemnification term		15 months
Total consideration		$ 20,330		20,300
Oxeye Security Limited \| Founder Holdback
Business Acquisition [Line Items]
Contingent consideration		$ 3,200
Number of contingent payment tranches \| tranche		3
Change in fair value of acquisition related contingent consideration			$ 900	$ 1,000
Oxeye Security Limited \| Founder Holdback \| Business Combination, Contingent Consideration, Tranche One
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage		33.30%
Oxeye Security Limited \| Founder Holdback \| Business Combination, Contingent Consideration, Tranche Two
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage		33.30%
Oxeye Security Limited \| Founder Holdback \| Business Combination, Contingent Consideration, Tranche Three
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage		33.30%
Oxeye Security Limited \| Developed Technology
Business Acquisition [Line Items]
Intangible assets acquired, useful life		3 years

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		Jul. 31, 2024	Mar. 20, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Goodwill	[1]	$ 16,017		$ 8,145
Oxeye Security Limited
Business Acquisition [Line Items]
Cash and cash equivalents			$ 120
Goodwill			8,055
Prepaid expenses and other current assets			121
Accrued expenses and payroll			(3,582)
Deferred tax liability			(660)
Net assets acquired			20,330
Oxeye Security Limited \| Developed Technology
Business Acquisition [Line Items]
Developed technology			$ 16,276

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 8,145	[1]
Acquisition of Oxeye	8,055
Foreign currency translation adjustments	(183)
Goodwill, ending balance	$ 16,017	[1]

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment			$ 0
Amortization of intangible assets	$ 2,300,000	$ 500,000	$ 3,420,000	$ 1,125,000

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 30,656	$ 7,114
Accumulated Amortization	(8,789)	(5,381)
Total future amortization	21,867	1,733
Developed technology from business combination
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	22,082	6,200
Accumulated Amortization	(7,395)	(4,467)
Total future amortization	$ 14,687	$ 1,733
Weighted average remaining amortization period (years)	2 years 4 months 24 days	9 months 18 days
Developed technology from asset acquisitions
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 8,574	$ 914
Accumulated Amortization	(1,394)	(914)
Total future amortization	$ 7,180	$ 0
Weighted average remaining amortization period (years)	2 years 9 months 18 days	0 years

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 4,625
2026	7,848
2027	7,848
2028	1,546
Total future amortization	$ 21,867	$ 1,733

Team Member Benefit Plans (Deta

Team Member Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Team Member Benefit Plans (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Retirement Benefits [Abstract]
Defined contribution plan, contribution amount	$ 1.2	$ 1	$ 3	$ 2.7

Equity - Narrative (Details)

Equity - Narrative (Details) $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended
Equity - Narrative (Details) $ in Thousands	Jun. 30, 2022 shares	May 31, 2021 USD ($) shares	Jul. 31, 2024 USD ($) distribution shares	Jul. 31, 2023 USD ($) shares	Jul. 31, 2024 USD ($) distribution shares	Jul. 31, 2023 USD ($) shares	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			$ 48,969	$ 46,368	$ 91,221	$ 78,698
Compensation expense not yet recognized			$ 12,900		12,900
Grant date fair value of RSUs granted		$ 8,800
Offering period (in months)			24 months
Tax benefit for stock-based compensation expense			$ 0	3,600	$ 0	6,400
Number of distributions, donation \| distribution			4		4
Charitable donation of common stock			$ 2,957	2,675	$ 5,914	5,350
Shares subject to outstanding common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			3,400	4,700	$ 6,900	9,500
Period for recognition (in years)					1 year 2 months 12 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			41,300	29,900	$ 76,800	53,200
Period for recognition (in years)					2 years 10 months 24 days
Compensation expense not yet recognized			450,600		$ 450,600
RSUs \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			300	400	$ 700	800
Period for recognition (in years)					4 years 3 months 18 days
Compensation expense not yet recognized			3,600		$ 3,600
RSUs \| Minimum \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					3 years
RSUs \| Maximum \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					7 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			300	(100)	$ 900	300
Period for recognition (in years)					1 year 4 months 24 days
Compensation expense not yet recognized			1,700		$ 1,700
RSUs granted in period (in shares) \| shares	400,000
Award vesting percentage	100%
PSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	0%
PSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%
2021 Equity Incentive Plan \| RSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)					2 years
2021 Equity Incentive Plan \| RSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)					4 years
2021 Employee Stock Purchase Plan \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense			3,500	$ 6,700	$ 6,100	$ 11,200
Period for recognition (in years)					1 year 9 months 18 days
Compensation expense not yet recognized			11,400		$ 11,400
Plan modification, cost not yet recognized			$ 1,000		$ 1,000
Class B Common Stock \| RSUs \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted in period (in shares) \| shares		3,000,000
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares) \| shares									1,635,545
Aggregate principal amount, donation							$ 11,800	$ 10,700
Charitable donation of common stock (in shares) \| shares			67,015	52,647	120,241	133,389
Charitable donation of common stock			$ 2,900	$ 2,700	$ 5,900	$ 5,300

Equity - Schedule of Stock Rese

Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares shares in Thousands	Jul. 31, 2024	Jan. 31, 2024	Jan. 31, 2023
Class of Stock [Line Items]
Options issued and outstanding (in shares)	7,481	8,503
Shares available for issuance under Equity Incentive Plans (in shares)	29,797	24,868	21,483
Class A and Class B common stock
Class of Stock [Line Items]
Options issued and outstanding (in shares)	7,481	8,503
Shares available for issuance under Equity Incentive Plans (in shares)	29,797	24,868
Shares reserved for issuance to charitable organizations (in shares)	1,284	1,404
Common stock reserved for future issuance (in shares)	57,689	51,103
RSUs and PSUs \| Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	12,405	10,930
ESPP \| Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	6,722	5,398

Equity - Awards Available for G

Equity - Awards Available for Grant (Details) - shares shares in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2024	Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
Balance, beginning of period (in shares)	24,868	21,483
Awards authorized (in shares)	7,878	7,557
Options cancelled and forfeited (in shares)	91	777
Options repurchased (in shares)	0	17
Balance, end of period (in shares)	29,797	24,868
RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
RSUs and PSUs granted (in shares)	(4,238)	(6,258)
RSUs and PSUs cancelled and forfeited (in shares)	1,198	1,292

Equity - Summary of Stock Optio

Equity - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Millions	6 Months Ended	12 Months Ended
	Jul. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2024 USD ($) $ / shares shares
Number of Stock Options Outstanding (in thousands)
Balance, beginning of period (in shares) \| shares	8,503
Options granted (in shares) \| shares	0
Options exercised (in shares) \| shares	(931)
Options cancelled (in shares) \| shares	(11)
Options forfeited (in shares) \| shares	(80)
Balance, end of period (in shares) \| shares	7,481	8,503
Options vested (in shares) \| shares	6,252
Options expected to vest (in shares) \| shares	7,481
Weighted Average Exercise Price
Balance, beginning of period (in USD per share) \| $ / shares	$ 13.03
Options granted (in USD per share) \| $ / shares	0
Options exercised (in USD per share) \| $ / shares	10.82
Options cancelled (in USD per share) \| $ / shares	13.75
Options forfeited (in USD per share) \| $ / shares	18.30
Balance, end of period (in USD per share) \| $ / shares	13.18	$ 13.03
Options vested (in USD per share) \| $ / shares	12.18
Options expected to vest (in USD per share) \| $ / shares	$ 13.18
Weighted Average Remaining Years
Outstanding (in years)	5 years 4 months 20 days	5 years 10 months 6 days
Options vested (in years)	5 years 1 month 17 days
Options expected to vest (in years)	5 years 4 months 20 days
Aggregate Intrinsic value (in millions)
Outstanding value \| $	$ 284.7	$ 499.2
Options vested \| $	244.2
Options expected to vest \| $	$ 284.7

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs shares in Thousands	6 Months Ended
	Jul. 31, 2024 $ / shares shares
Number of Shares
Balance, beginning of period (in shares)	7,701
Granted (in shares)	4,238
Vested (in shares)	(1,565)
Canceled/forfeited (in shares)	(1,198)
Balance, ending of period (in shares)	9,176
Weighted- Average grant date fair value
Balance, beginning of period (in USD per share) \| $ / shares	$ 47.20
Granted (in USD per share) \| $ / shares	53.15
Vested (in USD per share) \| $ / shares	48.70
Canceled/forfeited (in USD per share) \| $ / shares	48.44
Balance, ending of period (in USD per share) \| $ / shares	$ 49.48
Chief Executive Officer
Number of Shares
Granted (in shares)	3,000

Equity - Schedule of Weighted A

Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - ESPP	3 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield (as a percent)	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	4.70%	4.22%
Volatility (as a percent)	50.94%	40.95%
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	5.25%	5.30%
Volatility (as a percent)	60.50%	51%
Expected term (in years)	2 years	2 years

Equity - Stock-Based Compensati

Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 48,969	$ 46,368	$ 91,221	$ 78,698
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	2,076	1,698	3,931	3,112
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	19,881	21,295	37,278	35,059
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	16,114	12,477	28,450	24,179
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 10,898	$ 10,898	$ 21,562	$ 16,348

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 200		$ 7,800
Positions eliminated, percent					7%
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 771	$ 172	$ 1,777	$ 7,825

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 200		$ 7,800
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 771	172	$ 1,777	7,825
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges				1,300
Cost of revenue \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	46	0	463
Research and development \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	393	(12)	393	2,047
Sales and marketing \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	266	118	996	3,677
General and administrative \| Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 112	$ 20	$ 388	$ 1,638

Restructuring and Other Relat_5

Restructuring and Other Related Charges - Restructuring Accrual (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Restructuring Reserve [Roll Forward]
Charges		$ 200		$ 7,800
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning balance			$ 188
Charges	$ 771	$ 172	1,777	$ 7,825
Cash payments			(1,799)
Ending balance	$ 166		$ 166

Joint Venture and Equity Meth_3

Joint Venture and Equity Method Investment - Narrative (Details) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2024 USD ($) lease	Jul. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
Noncontrolling Interest [Line Items]
Stock-based compensation	$ 48,969	$ 46,368	$ 91,221	$ 78,698
Operating lease, number of leases entered into \| lease			2
Operating lease, total lease payments	500		$ 500
Operating lease liabilities	500		500
Operating lease expense	100	100	300	300
Equity method investment, impairment					$ 8,900
Equity method investment					$ 0
Loss from equity method investment, net of tax	0	(917)	0	(1,665)
Arch (Meltano Inc.)
Noncontrolling Interest [Line Items]
Loss from equity method investment, net of tax	$ 0	900	$ 0	1,700
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Ownership percentage	54%		54%
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Stock-based compensation	$ (100)	$ (200)	$ (200)	$ (2,700)
Compensation expense not yet recognized	$ 9,400		$ 9,400
Period for recognition (in years)			4 years 1 month 6 days

Joint Venture and Equity Meth_4

Joint Venture and Equity Method Investment - Supplemental Information Related to Operating Leases (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2024 USD ($)
Leases [Abstract]
Weighted-average remaining lease term (in years)	1 year 9 months
Weighted-average discount rate	3.50%
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 372
Cash paid for amounts included in the measurement of lease liabilities	$ 294

Joint Venture and Equity Meth_5

Joint Venture and Equity Method Investment - Schedule of Intercompany Eliminations (Details) - USD ($)		3 Months Ended			6 Months Ended
		Jul. 31, 2024		Jul. 31, 2023	Jul. 31, 2024		Jul. 31, 2023	Jan. 31, 2024
Noncontrolling Interest [Line Items]
Revenue		$ 182,584,000		$ 139,581,000	$ 351,771,000		$ 266,459,000
Cost of revenue		21,370,000		14,696,000	40,146,000		28,635,000
Gross profit		161,214,000		124,885,000	311,625,000		237,824,000
Sales and marketing		97,778,000		92,116,000	190,202,000		178,653,000
Total operating expenses		202,219,000		178,942,000	406,270,000		350,114,000
Loss from operations		(41,005,000)		(54,057,000)	(94,645,000)		(112,290,000)
Interest income		12,827,000		9,112,000	24,857,000		16,427,000
Other income (expense), net		1,032,000		(1,330,000)	465,000		(1,077,000)
Net income (loss)		12,274,000		(51,208,000)	(42,613,000)		(104,107,000)
Net loss attributable to noncontrolling interest		(675,000)		(1,128,000)	(918,000)		(1,558,000)
Cash and cash equivalents	[1]	438,616,000			438,616,000			$ 287,996,000
Property and equipment, net	[1]	2,899,000			2,899,000			2,954,000
Operating lease right-of-use assets		482,000	[1]		482,000	[1]		405,000
TOTAL ASSETS	[1]	1,376,262,000			1,376,262,000			1,317,861,000
Total liabilities	[1]	688,258,000			688,258,000			699,927,000
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Revenue		1,775,000		1,609,000	3,421,000		3,073,000
Cost of revenue		535,000		560,000	1,019,000		1,051,000
Gross profit		1,240,000		1,049,000	2,402,000		2,022,000
Sales and marketing		1,410,000		1,960,000	3,046,000		4,044,000
Research and development		578,000		727,000	366,000		2,683,000
General and administrative		907,000		1,407,000	1,745,000		(37,000)
Total operating expenses		2,895,000		4,094,000	5,157,000		6,690,000
Loss from operations		(1,655,000)		(3,045,000)	(2,755,000)		(4,668,000)
Interest income		230,000		240,000	457,000		555,000
Other income (expense), net		(42,000)		293,000	305,000		562,000
Net loss before income taxes		(1,467,000)		(2,512,000)	(1,993,000)		(3,551,000)
Net income (loss)		(1,467,000)		(2,512,000)	(1,993,000)		(3,551,000)
Net loss attributable to noncontrolling interest		(675,000)		$ (1,128,000)	(918,000)		$ (1,558,000)
Cash and cash equivalents		40,756,000			40,756,000			43,896,000
Property and equipment, net		277,000			277,000			489,000
Operating lease right-of-use assets		482,000			482,000			405,000
Other assets		3,465,000			3,465,000			2,835,000
TOTAL ASSETS		44,980,000			44,980,000			47,625,000
Total liabilities		$ 6,464,000			$ 6,464,000			$ 6,080,000

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Apr. 30, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ (39,420)		$ 4,016	$ (26,710)	$ 5,502
Loss before income taxes and loss from equity method investment	27,146		$ 46,275	69,323	$ 96,940
Unrecognized tax benefits	349,900			349,900
Unrecognized tax benefits that would effect tax rate	160,100			160,100
Unrecognized tax benefits, current	159,500			159,500
Interest and penalties recognized				55,400		$ 52,100
Unrecognized tax benefits, income tax penalties expense	$ (46,700)	$ 8,600		$ (38,100)		$ 254,900

Net Income (Loss) per Share - S

Net Income (Loss) per Share - Schedule of Earning Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Numerator:
Net income (loss) attributable to GitLab	$ 12,949	$ (50,080)	$ (41,695)	$ (102,549)
Denominator:
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic (in shares)	159,677	153,644	158,973	152,683
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares)	166,346	153,644	158,973	152,683
Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ 0.08	$ (0.33)	$ (0.26)	$ (0.67)
Net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ 0.08	$ (0.33)	$ (0.26)	$ (0.67)
Stock options
Denominator:
Dilutive impact of options and restrictive stock units (in shares)	$ 5,452	$ 0	$ 0	$ 0
RSUs
Denominator:
Dilutive impact of options and restrictive stock units (in shares)	1,166	0	0	0
ESPP
Denominator:
Dilutive impact of options and restrictive stock units (in shares)	$ 51	$ 0	$ 0	$ 0

Net Income (Loss) per Share -_2

Net Income (Loss) per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2024	Jan. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	7,141	21,535
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	0	9,933
Unvested restricted stock in connection with business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	2	3
Unvested early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	0	63
Unvested RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	6,917	11,465
Shares subject to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	222	71

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 135.1
Estimate of possible loss	$ 2.1	$ 2.2